We investigated the correlation between in vitro susceptibility of CD3 ؉ T lymphocytes to equine arteritis virus (EAV) infection and establishment of persistent infection among 14 stallions following natural infections. The data showed that carrier stallions with a CD3 ؉ T lymphocyte susceptibility phenotype to in vitro EAV infection may be at higher risk of becoming carriers than those that lack this phenotype (P ؍ 0.0002).
Equine arteritis virus (EAV) is a small, enveloped virus with a positive-sense, single-stranded RNA genome that belongs to the family Arteriviridae (genus Arterivirus, order Nidovirales) (4,11). It is the causal agent of equine viral arteritis (EVA), which is a respiratory and reproductive disease of horses and other equids (3,14). While the vast majority of natural infections with EAV are unapparent or subclinical (3, 2, 14), occasional outbreaks of EVA occur that are characterized by influenza-like signs in adult horses, abortion in mares, and the possibility of pneumonia in foals (7,14). Following EAV infection, a variable proportion of stallions (30 to 70%) can become persistently infected and continuously shed the virus in their semen (14; S. M. Neu, P. J. Timoney, and W. H. McCollum, presented at the 5th International Conference Equine Infectious Diseases, Lexington, Kentucky, 1987). Carrier stallions are the natural reservoir of EAV; they ensure the virus is maintained in equine populations between breeding seasons (14, 16). The continued growth in the international trade of horses and semen has served as a significant means of dissemination of EAV strains around the world (1,8,(13)(14)(15)(16). Therefore, identification of carrier stallions is of critical epidemiological importance in the prevention and control of EAV infection in countries worldwide (2,3,(12)(13)(14). While the mechanism of persistence of EAV in the male reproductive tract is not clear, it has been established that viral persistence in the stallion is testosterone dependent (9; T. V. Little, G. R. Holyoak, W. H. McCollum, and P. J. Timoney, presented at the 6th International Conference on Equine Infectious Diseases, Cambridge, England, 1992). Although multiple factors